Advancing your investigative compound to a drug candidate

Frontage offers comprehensive services in analytical testing and formulation development, drug metabolism and pharmacokinetics (DMPK), bioanalysis, preclinical safety and toxicology, and early-phase clinical studies.

Frontage’s Clinical Services team collaborates closely with every client to develop a unique approach to overcome the challenges of each study while maximizing efficiency and mitigating risk, providing comprehensive clinical services for drug development. We leverage our best practices in study design and execution to advance each study to a go-no-go decision.  

• Over 25 years of experience in the execution of comprehensive Phase I-IIa studies 
• Expertise with a broad range of study types and  a wide variety of delivery systems 
• 2 full-time Physicians serving as PIs 
• Over 50% of staff with advanced degrees 
• Located near NYC with access to one of the most  diverse study populations and acclaimed medical professionals and facilities 

Our clinical services team offers a complete suite of services from study design to delivery of the final report. 

About the Clinic

Our Phase I facility is located in Secaucus, New Jersey.

Clinical Study Experience

With over 25 years of early stage clinical research expertise, Frontage has completed 250+ studies.

Biometrics

Built on industry-leading standards

Overview of Frontage Clinical Services 

Frontage has successfully assisted clients to advance hundreds of molecules through early-phase clinical development to commercial launch in global markets. We are committed to providing the expertise to ensure the highest quality and compliance for the successful development of important therapies and products for patients.